Ramesh “Sunny” Balwani, the former president and chief operating officer of Theranos, is serving a federal prison term of 12 years and 11 months after a jury found him guilty on all 12 counts brought against him. The conviction followed years of scrutiny of the blood-testing startup and its representations to investors, doctors and patients. Balwani, who was both a senior executive at Theranos and formerly in a relationship with founder Elizabeth Holmes, was tried separately from Holmes. His conviction covers both investor- and patient-related fraud charges, making the scope of his verdict different from hers.
As of October 2026, recent reporting places Balwani at FCI Lompoc II in Lompoc, California, with a projected release date of April 21, 2033. Some older reports identify a different federal institution or release year; those details can become obsolete following transfers and recalculations. The current published date is a projection, not a guaranteed discharge date.
His Role at Theranos
Balwani joined Theranos in 2009 and served in a top operational role as Holmes sought investors and commercial partners for a supposedly revolutionary method of analyzing blood. Prosecutors said executives falsely represented the effectiveness and reliability of the company’s proprietary devices, with the consequences extending beyond financial losses. The trial explored what company leadership knew about technical failures and how problems were presented to outside parties.
The company’s valuation climbed as it formed relationships with major businesses and attracted wealthy investors. Questions about test accuracy, the use of third-party analyzers and internal validation eventually exposed a gap between Theranos’s public claims and its laboratory performance. Theranos closed in 2018, and federal charges followed.
What Charges Led to His Conviction?
In July 2022, a federal jury convicted Balwani of all 12 counts, including conspiracy to commit wire fraud and substantive wire-fraud offenses related to investors and patients. The jury’s decision followed testimony from former employees, business partners and others familiar with operations at Theranos. Balwani contested the government’s account during the proceedings, but the verdict established his criminal liability on the charged offenses.
On December 7, 2022, U.S. District Judge Edward Davila sentenced him to 155 months in prison and imposed a period of supervised release. The sentence is often described as nearly 13 years, or 12 years and 11 months. Balwani entered federal custody in April 2023. The timing matters: a prison sentence’s announced length is not the same thing as the number of calendar years remaining after credit for detention and other legally available reductions.
Appeals and the Restitution Order
In February 2025, the Ninth Circuit upheld the fraud convictions, custodial sentences and a restitution order tied to losses at Theranos. The district court ordered Holmes and Balwani jointly and severally responsible for approximately $452 million, meaning the order does not simply divide the sum into two equal independent debts. Restitution addresses victim losses and continues to matter even while the defendants serve prison terms.
Balwani continued seeking appellate relief, but reporting in October 2026 says the U.S. Supreme Court declined to review his case. That leaves the existing criminal judgment operative. An unsuccessful appeal does not create a new conviction or restart the prison sentence; it generally leaves the lower-court result in place.
Where Is Sunny Balwani Now?
Balwani initially reported to FCI Terminal Island in California in April 2023. Later facility changes have complicated online information about where he is held. Recent reporting places him at FCI Lompoc II, a low-security federal institution. A facility name should be checked through current Bureau of Prisons information when precise location is important, particularly for family contacts or legal correspondence.
When Is His Expected Release?
Recent October 2026 reporting places his projected release on April 21, 2033. Unlike a judge’s 155-month sentence, this is an administrative calculation based on the federal prison system’s records and applicable credits. A projected date may move because of sentence computation, program eligibility, conduct or other lawful adjustments. There is no verified basis to describe the projection as a promised early pardon or a reversal of his conviction.
What Distinguishes His Case From Elizabeth Holmes’s?
Both executives were prosecuted over Theranos, but different juries evaluated their cases and returned different verdicts. Holmes was convicted on investor-related fraud counts, while Balwani was convicted on all 12 counts brought against him, including patient-related charges. Their original sentences differed, and they serve time at separate correctional facilities. Both were subject to the same substantial restitution order.
Current Legal Status
Balwani remains a federal inmate serving a valid criminal sentence. His conviction was upheld on appeal, and the expected April 2033 release date remains subject to federal prison calculations. Any article about the case should state the facility and date with an “as of” reference, because both may change without a new court verdict.
